import type { Tool, InputConfig, InputOption, FormSectionConfig } from './types';
import { ScalingIcon } from 'lucide-react';
import { getValidationSchema } from './toolValidation';

const scoradIntensityOptions: InputOption[] = [
  { value: 0, label: '0-None' },
  { value: 1, label: '1-Mild' },
  { value: 2, label: '2-Moderate' },
  { value: 3, label: '3-Severe' },
];

export const scoradTool: Tool = {
  id: 'scorad',
  name: 'SCORing Atopic Dermatitis (SCORAD)',
  acronym: 'SCORAD',
  description:
    'Developed by the European Task Force on Atopic Dermatitis in 1993, SCORAD is a comprehensive tool for assessing AD severity. It uniquely combines objective clinician-assessed signs (extent and intensity) with patient-reported symptoms (itch and sleep loss).',
  condition: 'Atopic Dermatitis / Eczema',
  keywords: [
    'scorad',
    'atopic dermatitis',
    'ad',
    'eczema',
    'severity',
    'extent',
    'intensity',
    'subjective symptoms',
  ],
  sourceType: 'Expert Consensus',
  icon: ScalingIcon,
  rationale:
    "The SCORAD index was developed by the European Task Force on Atopic Dermatitis to provide a consensus method for assessing the severity of atopic dermatitis. It incorporates objective clinical signs (Extent - Part A; Intensity - Part B) and subjective patient symptoms (Part C). The formula is: SCORAD = A/5 + 7B/2 + C. An 'objective SCORAD' (oSCORAD) variant excludes subjective symptoms. The maximum possible score is 103.",
  clinicalPerformance:
    'SCORAD is extensively validated. It shows strong correlation with other measures like POEM and IGA (kappa = 0.68) and good internal consistency. A version adapted for Black skin correlated well with physician-assessed SCORAD (r = 0.66). The minimal clinically important difference (MCID) is 8.7 points. Its inter-rater reliability is lower than EASI and SASSAD, particularly due to variability in the body surface area (BSA) component.',
  formSections: [
    {
      id: 'scorad_group_a',
      title: 'Part A: Extent',
      gridCols: 1,
      inputs: [
        {
          id: 'extentPercent',
          label: 'A: Body Surface Area Involved (%)',
          type: 'number',
          min: 0,
          max: 100,
          defaultValue: 0,
          description: "Calculated using the 'Rule of Nines'. Score: 0–100.",
          validation: getValidationSchema('number', undefined, 0, 100),
        },
      ],
    },
    {
      id: 'scorad_group_b',
      title: 'Part B: Intensity',
      gridCols: 3,
      description:
        'Assess the average intensity of six clinical signs across affected areas (0=None, 1=Mild, 2=Moderate, 3=Severe). Sum of these six signs gives a total intensity score from 0 to 18.',
      inputs: [
        {
          id: 'intensityRedness',
          label: 'Erythema',
          type: 'select',
          options: scoradIntensityOptions,
          defaultValue: 0,
          validation: getValidationSchema('select', scoradIntensityOptions, 0, 3),
        },
        {
          id: 'intensityEdema',
          label: 'Edema/Papulation',
          type: 'select',
          options: scoradIntensityOptions,
          defaultValue: 0,
          validation: getValidationSchema('select', scoradIntensityOptions, 0, 3),
        },
        {
          id: 'intensityOozing',
          label: 'Oozing/Crusting',
          type: 'select',
          options: scoradIntensityOptions,
          defaultValue: 0,
          validation: getValidationSchema('select', scoradIntensityOptions, 0, 3),
        },
        {
          id: 'intensityExcoriation',
          label: 'Excoriation',
          type: 'select',
          options: scoradIntensityOptions,
          defaultValue: 0,
          validation: getValidationSchema('select', scoradIntensityOptions, 0, 3),
        },
        {
          id: 'intensityLichenification',
          label: 'Lichenification',
          type: 'select',
          options: scoradIntensityOptions,
          defaultValue: 0,
          validation: getValidationSchema('select', scoradIntensityOptions, 0, 3),
        },
        {
          id: 'intensityDryness',
          label: 'Dryness (of non-affected skin)',
          type: 'select',
          options: scoradIntensityOptions,
          defaultValue: 0,
          validation: getValidationSchema('select', scoradIntensityOptions, 0, 3),
        },
      ],
    },
    {
      id: 'scorad_group_c',
      title: 'Part C: Subjective Symptoms',
      gridCols: 2,
      description:
        'Patient rates average itch and sleep loss over the past three days on a Visual Analog Scale (VAS) from 0 (none) to 10 (most severe). The two scores are added together (Score: 0–20).',
      inputs: [
        {
          id: 'pruritusVAS',
          label: 'Pruritus (Itch) VAS (0-10)',
          type: 'number',
          min: 0,
          max: 10,
          defaultValue: 0,
          validation: getValidationSchema('number', undefined, 0, 10),
        },
        {
          id: 'sleepLossVAS',
          label: 'Sleeplessness VAS (0-10)',
          type: 'number',
          min: 0,
          max: 10,
          defaultValue: 0,
          validation: getValidationSchema('number', undefined, 0, 10),
        },
      ],
    },
  ],
  calculationLogic: (inputs) => {
    const A = Number(inputs.extentPercent) || 0;
    const B_sum =
      (Number(inputs.intensityRedness) || 0) +
      (Number(inputs.intensityEdema) || 0) +
      (Number(inputs.intensityOozing) || 0) +
      (Number(inputs.intensityExcoriation) || 0) +
      (Number(inputs.intensityLichenification) || 0) +
      (Number(inputs.intensityDryness) || 0);
    const C_sum = (Number(inputs.pruritusVAS) || 0) + (Number(inputs.sleepLossVAS) || 0);
    const totalScoradScore = A / 5 + (7 * B_sum) / 2 + C_sum;
    const objectiveScorad = A / 5 + (7 * B_sum) / 2; // Objective SCORAD (oSCORAD)

    const score = parseFloat(totalScoradScore.toFixed(1));
    let severityCategory = '';
    if (score < 25) severityCategory = 'Mild AD';
    else if (score <= 50) severityCategory = 'Moderate AD';
    else severityCategory = 'Severe AD';

    const interpretation = `SCORAD Score: ${score} (Range: 0-103). Severity: ${severityCategory}.
Objective SCORAD (oSCORAD): ${objectiveScorad.toFixed(1)} (Range: 0-83).
Formula: SCORAD = A/5 + (7*B)/2 + C.`;

    return {
      score,
      interpretation,
      details: {
        Part_A_Extent_BSA: A,
        Part_B_Intensity_Sum: B_sum,
        Part_C_Subjective_Symptoms_Sum: C_sum,
        Calculated_oSCORAD: parseFloat(objectiveScorad.toFixed(1)),
        Total_SCORAD_Score: score,
        Severity_Category: severityCategory,
      },
    };
  },
  references: [
    'Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of Care for the Management of Atopic Dermatitis: Section 1. Diagnosis and Assessment of Atopic Dermatitis. Journal of the American Academy of Dermatology. 2014;70(2):338-51. doi:10.1016/j.jaad.2013.10.010.',
    'Oranje AP, Glazenburg EJ, Wolkerstorfer A, de Waard-van der Spek FB. Practical Issues on Interpretation of Scoring Atopic Dermatitis: The SCORAD Index, Objective SCORAD and the Three-Item Severity Score. The British Journal of Dermatology. 2007;157(4):645-8. doi:10.1111/j.1365-2133.2007.08112.x.',
    'Gelmetti C, Colonna C. The Value of SCORAD and Beyond. Towards a Standardized Evaluation of Severity?. Allergy. 2004;59 Suppl 78:61-5. doi:10.1111/j.1398-9995.2004.00651.x.',
    'Chu DK, Schneider L, Asiniwasis RN, et al. Atopic Dermatitis (Eczema) Guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- And Institute of Medicine-Based Recommendations. Annals of Allergy, Asthma & Immunology. 2024;132(3):274-312. doi:10.1016/j.anai.2023.11.009.',
    'Ständer S. Atopic Dermatitis. The New England Journal of Medicine. 2021;384(12):1136-1143. doi:10.1056/NEJMra2023911.',
    'Barbarot S, Aubert H, Stalder JF, Roye S, Delarue A. The Patient-Oriented Scoring of Atopic Dermatitis and SCORAD in Young Children: New Data on Interpretability and Clinical Usefulness. Journal of the European Academy of Dermatology and Venereology. 2024;38(1):175-181. doi:10.1111/jdv.19494.',
    'Silverberg JI, Margolis DJ, Boguniewicz M, et al. Validation of Five Patient-Reported Outcomes for Atopic Dermatitis Severity in Adults. The British Journal of Dermatology. 2020;182(1):104-111. doi:10.1111/bjd.18002.',
    "Faye O, Meledie N'Djong AP, Diadie S, et al. Validation of the Patient-Oriented SCORing for Atopic Dermatitis Tool for Black Skin. Journal of the European Academy of Dermatology and Venereology. 2020;34(4):795-799. doi:10.1111/jdv.15999.",
    'Schram ME, Spuls PI, Leeflang MM, et al. EASI, (Objective) SCORAD and POEM for Atopic Eczema: Responsiveness and Minimal Clinically Important Difference. Allergy. 2012;67(1):99-106. doi:10.1111/j.1398-9995.2011.02719.x.',
    'Zhao CY, Tran AQ, Lazo-Dizon JP, et al. A Pilot Comparison Study of Four Clinician-Rated Atopic Dermatitis Severity Scales. The British Journal of Dermatology. 2015;173(2):488-97. doi:10.1111/bjd.13846.',
    'Jacobson ME, Leshem YA, Apfelbacher C, et al. Measuring Signs of Atopic Dermatitis in Clinical Practice: A HOME-CP Consensus Statement. JAMA Dermatology. 2024;160(8):878-886. doi:10.1001/jamadermatol.2024.1162.',
    'Silverberg JI, Lei D, Yousaf M, et al. Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and Other Measures of Atopic Dermatitis: A Validation Study. Annals of Allergy, Asthma & Immunology. 2020;125(1):78-83. doi:10.1016/j.anai.2020.03.006.',
  ],
};
